Skip to main content
Top
Published in: Rheumatology International 2/2017

01-02-2017 | Public Health

Low vaccination rates among patients with rheumatoid arthritis in a German outpatient clinic

Authors: Marco Krasselt, Jean-Philipp Ivanov, Christoph Baerwald, Olga Seifert

Published in: Rheumatology International | Issue 2/2017

Login to get access

Abstract

Patients with rheumatoid arthritis (RA) are at an increased risk of acquiring infections due to two reasons: the disease itself and the immunosuppressive therapy. Vaccinations against preventable diseases are therefore of utmost importance for these group of patients. To estimate vaccination frequencies among patients with rheumatoid arthritis, we studied patients in a survey and calculated vaccination rates based on their vaccination documents. Patients have been recruited from our outpatient clinic during one of their routine visits. For the statistical analysis, they have been divided by age (≥60 vs <60 years) and medication (DMARD, Biologics, TNF inhibitors) for further subgroup analysis. Among the studied patients (n = 331), we found rather low vaccination rates, in particular for the strongly recommended vaccines against Pneumococcus and Influenza (33 and 53%, respectively). Furthermore, protection rates for important basic vaccinations, e.g. against Pertussis, were found to be very low with 12% only. Beside these findings, we saw age-dependent differences for a variety of vaccines: while Pneumococcus and Influenza vaccines were more often given to patients ≥60 years, MMR, Pertussis, Diphtheria and Hepatitis were significantly more often applied to younger patients. Vaccination rates have to be improved among RA patients, in particular for vaccines protecting from respiratory tract infections such as Pneumococcus.
Literature
1.
go back to reference Wolfe F, Mitchell DM, Sibley JT, Fries JF, Bloch DA, Williams CA et al (1994) The mortality of rheumatoid arthritis. Arthritis Rheum 37(4):481–494CrossRefPubMed Wolfe F, Mitchell DM, Sibley JT, Fries JF, Bloch DA, Williams CA et al (1994) The mortality of rheumatoid arthritis. Arthritis Rheum 37(4):481–494CrossRefPubMed
2.
3.
go back to reference Krasselt ML, Wagner U (2014) Ageing and immunity. Osteology 23(3):195–201 Krasselt ML, Wagner U (2014) Ageing and immunity. Osteology 23(3):195–201
4.
go back to reference Widdifield J, Bernatsky S, Paterson JM, Gunraj N, Thorne JC, Pope J et al (2013) Serious infections in a population-based cohort of 86,039 seniors with rheumatoid arthritis. Arthritis Care Res (Hoboken) 65(3):353–361. doi:10.1002/acr.21812 CrossRef Widdifield J, Bernatsky S, Paterson JM, Gunraj N, Thorne JC, Pope J et al (2013) Serious infections in a population-based cohort of 86,039 seniors with rheumatoid arthritis. Arthritis Care Res (Hoboken) 65(3):353–361. doi:10.​1002/​acr.​21812 CrossRef
6.
go back to reference Listing J, Strangfeld A, Kary S, Rau R, von Hinueber U, Stoyanova-Scholz M et al (2005) Infections in patients with rheumatoid arthritis treated with biologic agents. Arthritis Rheum 52(11):3403–3412. doi:10.1002/art.21386 CrossRefPubMed Listing J, Strangfeld A, Kary S, Rau R, von Hinueber U, Stoyanova-Scholz M et al (2005) Infections in patients with rheumatoid arthritis treated with biologic agents. Arthritis Rheum 52(11):3403–3412. doi:10.​1002/​art.​21386 CrossRefPubMed
7.
go back to reference van Assen S, Agmon-Levin N, Elkayam O, Cervera R, Doran MF, Dougados M et al (2011) EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases. Ann Rheum Dis 70(3):414–422. doi:10.1136/ard.2010.137216 CrossRefPubMed van Assen S, Agmon-Levin N, Elkayam O, Cervera R, Doran MF, Dougados M et al (2011) EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases. Ann Rheum Dis 70(3):414–422. doi:10.​1136/​ard.​2010.​137216 CrossRefPubMed
8.
go back to reference Hua C, Barnetche T, Combe B, Morel J (2014) Effect of methotrexate, anti-tumor necrosis factor alpha, and rituximab on the immune response to influenza and pneumococcal vaccines in patients with rheumatoid arthritis: a systematic review and meta-analysis. Arthritis Care Res (Hoboken) 66(7):1016–1026. doi:10.1002/acr.22246 CrossRef Hua C, Barnetche T, Combe B, Morel J (2014) Effect of methotrexate, anti-tumor necrosis factor alpha, and rituximab on the immune response to influenza and pneumococcal vaccines in patients with rheumatoid arthritis: a systematic review and meta-analysis. Arthritis Care Res (Hoboken) 66(7):1016–1026. doi:10.​1002/​acr.​22246 CrossRef
12.
go back to reference Krasselt M, Baerwald C, Wagner U, Rossol M (2013) CD56+ monocytes have a dysregulated cytokine response to lipopolysaccharide and accumulate in rheumatoid arthritis and immunosenescence. Arthritis Res Ther 15(5):R139. doi:10.1186/ar4321 CrossRefPubMedPubMedCentral Krasselt M, Baerwald C, Wagner U, Rossol M (2013) CD56+ monocytes have a dysregulated cytokine response to lipopolysaccharide and accumulate in rheumatoid arthritis and immunosenescence. Arthritis Res Ther 15(5):R139. doi:10.​1186/​ar4321 CrossRefPubMedPubMedCentral
13.
go back to reference Wagner UG, Koetz K, Weyand CM, Goronzy JJ (1998) Perturbation of the T cell repertoire in rheumatoid arthritis. Proc Natl Acad Sci USA 95(24):14447–14452CrossRefPubMedPubMedCentral Wagner UG, Koetz K, Weyand CM, Goronzy JJ (1998) Perturbation of the T cell repertoire in rheumatoid arthritis. Proc Natl Acad Sci USA 95(24):14447–14452CrossRefPubMedPubMedCentral
15.
go back to reference Giat E, Lidar M (2015) Vaccinations in Rheumatoid Arthritis. In: Shoenfeld Y, Agmon-Levin N, Tomljenovic L (eds) Vaccines & autoimmunity, vol 1, 1st edn. Wiley, Hoboken, pp 233–246CrossRef Giat E, Lidar M (2015) Vaccinations in Rheumatoid Arthritis. In: Shoenfeld Y, Agmon-Levin N, Tomljenovic L (eds) Vaccines & autoimmunity, vol 1, 1st edn. Wiley, Hoboken, pp 233–246CrossRef
16.
go back to reference RKI (2015) Empfehlungen der Ständigen Impfkommission (STIKO) am Robert Koch-Institut: Epidemiologisches Bulletin 34/2015. doi:10.17886/EpiBull-2015-001 RKI (2015) Empfehlungen der Ständigen Impfkommission (STIKO) am Robert Koch-Institut: Epidemiologisches Bulletin 34/2015. doi:10.17886/EpiBull-2015-001
17.
go back to reference Goldacker S, Gause AM, Warnatz K, Kommission Pharmakotherapie der D (2013) Vaccination in adult patients with chronic inflammatory rheumatic diseases. Z Rheumatol 72 (7):690–694, 696–700, 702–694. doi:10.1007/s00393-013-1155-4 Goldacker S, Gause AM, Warnatz K, Kommission Pharmakotherapie der D (2013) Vaccination in adult patients with chronic inflammatory rheumatic diseases. Z Rheumatol 72 (7):690–694, 696–700, 702–694. doi:10.​1007/​s00393-013-1155-4
18.
go back to reference Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO 3rd et al (2010) 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 69(9):1580–1588. doi:10.1136/ard.2010.138461 CrossRefPubMed Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO 3rd et al (2010) 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 69(9):1580–1588. doi:10.​1136/​ard.​2010.​138461 CrossRefPubMed
19.
go back to reference von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP et al (2007) The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Epidemiology 18(6):800–804. doi:10.1097/EDE.0b013e3181577654 CrossRef von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP et al (2007) The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Epidemiology 18(6):800–804. doi:10.​1097/​EDE.​0b013e3181577654​ CrossRef
20.
21.
go back to reference Wotton CJ, Goldacre MJ (2012) Risk of invasive pneumococcal disease in people admitted to hospital with selected immune-mediated diseases: record linkage cohort analyses. J Epidemiol Commun Health 66(12):1177–1181. doi:10.1136/jech-2011-200168 CrossRef Wotton CJ, Goldacre MJ (2012) Risk of invasive pneumococcal disease in people admitted to hospital with selected immune-mediated diseases: record linkage cohort analyses. J Epidemiol Commun Health 66(12):1177–1181. doi:10.​1136/​jech-2011-200168 CrossRef
22.
go back to reference Costello R, Winthrop KL, Pye SR, Brown B, Dixon WG (2016) Influenza and pneumococcal vaccination uptake in patients with rheumatoid arthritis treated with immunosuppressive therapy in the UK: a retrospective cohort study using data from the clinical practice research datalink. PLoS ONE 11(4):e0153848. doi:10.1371/journal.pone.0153848 CrossRefPubMedPubMedCentral Costello R, Winthrop KL, Pye SR, Brown B, Dixon WG (2016) Influenza and pneumococcal vaccination uptake in patients with rheumatoid arthritis treated with immunosuppressive therapy in the UK: a retrospective cohort study using data from the clinical practice research datalink. PLoS ONE 11(4):e0153848. doi:10.​1371/​journal.​pone.​0153848 CrossRefPubMedPubMedCentral
23.
go back to reference Bingham CO 3rd, Looney RJ, Deodhar A, Halsey N, Greenwald M, Coding C et al (2010) Immunization responses in rheumatoid arthritis patients treated with rituximab: results from a controlled clinical trial. Arthritis Rheum 62(1):64–74. doi:10.1002/art.25034 CrossRefPubMed Bingham CO 3rd, Looney RJ, Deodhar A, Halsey N, Greenwald M, Coding C et al (2010) Immunization responses in rheumatoid arthritis patients treated with rituximab: results from a controlled clinical trial. Arthritis Rheum 62(1):64–74. doi:10.​1002/​art.​25034 CrossRefPubMed
24.
go back to reference Cantini F, Boccia S, Goletti D, Iannone F, Leoncini E, Panic N et al (2014) HBV reactivation in patients treated with antitumor necrosis factor-alpha (TNF-alpha) agents for rheumatic and dermatologic conditions: a systematic review and meta-analysis. Int J Rheumatol 2014:926836. doi:10.1155/2014/926836 CrossRefPubMedPubMedCentral Cantini F, Boccia S, Goletti D, Iannone F, Leoncini E, Panic N et al (2014) HBV reactivation in patients treated with antitumor necrosis factor-alpha (TNF-alpha) agents for rheumatic and dermatologic conditions: a systematic review and meta-analysis. Int J Rheumatol 2014:926836. doi:10.​1155/​2014/​926836 CrossRefPubMedPubMedCentral
26.
27.
go back to reference Seong SS, Choi CB, Woo JH, Bae KW, Joung CL, Uhm WS et al (2007) Incidence of tuberculosis in Korean patients with rheumatoid arthritis (RA): effects of RA itself and of tumor necrosis factor blockers. J Rheumatol 34(4):706–711PubMed Seong SS, Choi CB, Woo JH, Bae KW, Joung CL, Uhm WS et al (2007) Incidence of tuberculosis in Korean patients with rheumatoid arthritis (RA): effects of RA itself and of tumor necrosis factor blockers. J Rheumatol 34(4):706–711PubMed
28.
go back to reference Pai M, Zwerling A, Menzies D (2008) Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med 149(3):177–184CrossRefPubMedPubMedCentral Pai M, Zwerling A, Menzies D (2008) Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med 149(3):177–184CrossRefPubMedPubMedCentral
Metadata
Title
Low vaccination rates among patients with rheumatoid arthritis in a German outpatient clinic
Authors
Marco Krasselt
Jean-Philipp Ivanov
Christoph Baerwald
Olga Seifert
Publication date
01-02-2017
Publisher
Springer Berlin Heidelberg
Published in
Rheumatology International / Issue 2/2017
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-016-3608-y

Other articles of this Issue 2/2017

Rheumatology International 2/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.